Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Altcoin Rises 138% in One Month and Enters Top 20, What’s Behind the Rally? Here Are the Details

Altcoin Rises 138% in One Month and Enters Top 20, What’s Behind the Rally? Here Are the Details

BitcoinSistemiBitcoinSistemi2026/10/09 06:45

NEAR has entered the top 20 cryptocurrencies by market capitalization, surpassing Stellar, with a 138% increase in the last 30 days.

While the cryptocurrency market as a whole is experiencing selling pressure, NEAR Protocol’s native token has attracted investor attention with its strong performance. According to CoinGecko data, NEAR has gained approximately 138% in value over the past 30 days, placing it among the top 20 cryptocurrencies by market capitalization.

As of the time of writing, NEAR’s market capitalization had reached $7.2 billion, with a daily trading volume of $1.2 billion. This surge puts the token ahead of Stellar, which has a market capitalization of approximately $7 billion.

One of the key developments behind the rally was the growth of the NEAR Intents protocol, which enables transactions across different blockchains. The protocol’s cumulative transaction volume exceeded $31 billion. NEAR Intents allows users or AI agents to perform asset swaps and transfers between chains without directly dealing with complex bridging operations.

On the institutional side, the launch of the first US spot NEAR investment product attracted attention. Launched by Bitwise and traded on the NYSE Arca under the ticker symbol NRR, the product allows investors to access the NEAR price without directly holding the token.

It’s important to remember that the rise isn’t entirely risk-free. NEAR Intents’ deposit and withdrawal infrastructure was recently compromised with a $3.8 million attack. The project team announced that all stolen funds have been recovered. While the swift resolution of the incident eased market concerns, infrastructure security remains closely monitored.

NEAR’s future performance may be determined by ETF demand, the sustainability of Intents trading volume, and potential profit-taking following the rise. While the 138% increase indicates strong momentum, such rapid increases also raise the risk of volatility.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

BUZZ - RBC expects gradual improvement in North American and European building materials stocks in the third quarter

October 9 - RBC expects the performance of most European building material products to gradually improve quarter-on-quarter in Q3, but notes that geopolitical uncertainties in the US will continue to drive up cost inflation and increase market volatility. RBC anticipates that sales in Europe will remain sluggish due to heatwaves and rising mortgage rates, while a weak US housing market and the lack of a significant hurricane season will prompt roofing material companies to enter a destocking cycle. The firm is more optimistic about Germany’s Heidelberg Group (HEIG.DE), upgrading its rating to “outperform,” and points out that the company has handled the challenging quarter caused by extreme weather far better than its peers. Due to severe cost headwinds such as rising diesel and natural gas prices, RBC downgraded the ratings of US and French construction companies Knife River (KNF.N) and Saint-Gobain (SGOB.PA) from “outperform” to “market perform.” (For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. Since automated translations may contain errors or lack necessary context, Reuters does not guarantee their accuracy and provides them solely for the ease of the reader. Reuters assumes no liability for any damages or losses that may arise from the use of automated translation functions.)

路透社•2026/10/09 07:16

3D printing materials supplier Amaero (AMRO.US) restarts US IPO, fundraising drops 60% to $20 million

Amaero (AMRO.US) on Thursday resumed its initial public offering (IPO) plans in the United States and filed new documents with the U.S. Securities and Exchange Commission (SEC), revealing a reduced number of shares to be issued.

智通财经•2026/10/09 07:11

Even with Eli Lilly's endorsement, TRex Bio (TRXB.US) struggles to enjoy a premium, as the issue price drops to the lower limit of $14.

Early-stage biotechnology company TRex Bio has priced its IPO at the lower end of the range at $14 per share, raising $116.7 million and achieving a market capitalization of $384 million. The company will be listed on Nasdaq on Friday, with Eli Lilly expressing interest in increasing its stake.

智通财经•2026/10/09 07:09

Small molecule biotechnology company Iambic Therapeutics (IAM.US) IPO priced at $15-17 per share, aiming to raise $150 millions.

Iambic Therapeutics plans to raise $150 millions by issuing 9.4 million shares, with an offering price range of $15 to $17 per share.

智通财经•2026/10/09 07:08